CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescence

L Crozier, R Foy, R Adib, A Kar, JA Holt, AU Pareri… - Molecular Cell, 2023 - cell.com
Abnormal increases in cell size are associated with senescence and cell cycle exit. The
mechanisms by which overgrowth primes cells to withdraw from the cell cycle remain …

Cellular enlargement-A new hallmark of aging?

DM Davies, K van den Handel, S Bharadwaj… - Frontiers in Cell and …, 2022 - frontiersin.org
Years of important research has revealed that cells heavily invest in regulating their size.
Nevertheless, it has remained unclear why accurate size control is so important. Our recent …

Genome homeostasis defects drive enlarged cells into senescence

S Manohar, ME Estrada, F Uliana, K Vuina, PM Alvarez… - Molecular Cell, 2023 - cell.com
Cellular senescence refers to an irreversible state of cell-cycle arrest and plays important
roles in aging and cancer biology. Because senescence is associated with increased cell …

[HTML][HTML] The efferocytosis process in aging: Supporting evidence, mechanisms, and therapeutic prospects for age-related diseases

M Zhang, J Wei, Y Sun, C He, S Ma, X Pan… - Journal of Advanced …, 2024 - Elsevier
Background Aging is characterized by an ongoing struggle between the buildup of damage
caused by a combination of external and internal factors. Aging has different effects on …

Cotargeting CDK4/6 and BRD4 Promotes Senescence and Ferroptosis Sensitivity in Cancer

X Zhu, Z Fu, K Dutchak, A Arabzadeh, S Milette… - Cancer Research, 2024 - AACR
Abstract Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are approved for breast cancer
treatment and show activity against other malignancies, including KRAS-mutant non–small …

Natural polyphenols: A protective approach to reduce colorectal cancer

J Okpoghono, EF Isoje, UA Igbuku, O Ekayoda… - Heliyon, 2024 - cell.com
Background A form of cancer that affects the rectum or colon (large intestine) is called
colorectal cancer (CRC). The main risk factors for CRC include dietary, lifestyle, and …

The search for CDK4/6 inhibitor biomarkers has been hampered by inappropriate proliferation assays

R Foy, KX Lew, AT Saurin - NPJ Breast Cancer, 2024 - nature.com
CDK4/6 inhibitors are effective at treating advanced HR+/HER2-breast cancer, however
biomarkers that can predict response are urgently needed. We demonstrate here that …

Too big not to fail: Different paths lead to senescence of enlarged cells

A Khurana, Y Chadha, KM Schmoller - Molecular Cell, 2023 - cell.com
Too big not to fail: Different paths lead to senescence of enlarged cells: Molecular Cell Skip to
Main Content Advertisement Molecular Cell This journal offers authors two options (open access …

[HTML][HTML] Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

A Glaviano, SA Wander, RD Baird, KCH Yap… - Drug Resistance …, 2024 - Elsevier
Cell cycle dysregulation is a hallmark of cancer that promotes eccessive cell division. Cyclin-
dependent kinase 4 (CDK4) and cyclin-dependent kinase 6 (CDK6) are key molecules in …

Too big not to fail: emerging evidence for size‐induced senescence

S Manohar, GE Neurohr - The FEBS Journal, 2024 - Wiley Online Library
Cellular senescence refers to a permanent and stable state of cell cycle exit. This process
plays an important role in many cellular functions, including tumor suppression. It was first …